The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...

Early adopters of weight-loss drugs have tended to be wealthy because ... They’re thinking about inventory management, how to shift the size curve downward.” Before Handler lost 50 pounds on Zepbound, ...

Amid a flurry of weight loss readouts, a fresh-on-the-scene startup has come out with Phase I results showing weight loss at day 36 on par with or better than competitors, with few gastrointestinal ...

While this class of drugs becomes ever more prevalent, and the wide-ranging positive health outcomes become better known, ...

Recently, new pharmaceutical innovations have reshaped the weight loss treatment landscape. Among these, the prescription drugs Zepbound and Ozempic have risen in popularity. Both are used to ...

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year ... and tirzepatide (Mounjaro and Zepbound). The Cleveland Clinic study included ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide ...

Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterparts—but also experienced more nausea and ...

Terns Pharmaceuticals’ decision to drop its liver disease ambitions may yet pay off, after the biotech posted phase 1 data showing one of its other candidates induced 5% weight loss in a month.

Early adopters of weight-loss drugs have tended to ... how to shift the size curve downward.” Before Handler lost 50 pounds on Zepbound, the mall felt like a trap. The 40-year-old from ...